Biotech Hunter
Biotech Hunter
Home
Companies
Trials
People
Search
Clinical Trials Directory
Explore 118,444 clinical trials worldwide
Search
Showing 72001-72050 of 118,444 trials
Active filters:
Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruiting
Clinical Trials (118,444)
NCT05813236
NOVOSYN® Quick Versus MONOSYN® Quick Suture Material in Resective Periodontal Surgery
NA
Recruiting
84 participants
Started: Jun 28, 2023 · Completed: Jul 31, 2026
3 conditions
2 sponsors
1 location
NCT06034912
Fundus Effects of Repeated Low-Level Red-Light Therapy in Chinese Myopic Minors: A Randomized Controlled Clinical Trial
NA
Recruiting
70 participants
Started: Jun 28, 2023 · Completed: May 31, 2024
1 condition
1 sponsor
1 location
NCT05155163
Stepped Care for Patients to Optimize Whole Recovery
NA
Recruiting
204 participants
Started: Jun 28, 2023 · Completed: Aug 31, 2026
2 conditions
2 sponsors
2 locations
NCT05856448
A Study Evaluating the Effects of GLPG3667 Administered As Oral Treatment in Adult Participants with Active Systemic Lupus Erythematosus
PHASE2
Active, not recruiting
186 participants
Started: Jun 28, 2023 · Completed: Mar 31, 2026
1 condition
1 sponsor
84 locations
NCT05810402
Liver Cancer and Immunotherapy in the Liquid Biopsy Era
NA
Recruiting
60 participants
Started: Jun 28, 2023 · Completed: May 31, 2027
5 conditions
1 sponsor
1 location
NCT05783466
Dairy Lipids and Cardiometabolic Risk
NA
Recruiting
75 participants
Started: Jun 28, 2023 · Completed: Oct 31, 2026
1 condition
4 sponsors
2 locations
NCT05766774
FEED-Cystic Fibrosis (FEED-CF)
NA
Recruiting
60 participants
Started: Jun 28, 2023 · Completed: Jun 30, 2028
2 conditions
2 sponsors
1 location
NCT05785754
DCSZ11 as a Monotherapy and in Combination in Patients With Advanced or Metastatic Solid Tumors
PHASE1
Recruiting
320 participants
Started: Jun 28, 2023 · Completed: Dec 31, 2026
1 condition
1 sponsor
35 locations
NCT05913804
YTS104 Cell Injection for the Treatment of Relapsed or Refractory Multiple Myeloma
PHASE1
Recruiting
12 participants
Started: Jun 28, 2023 · Completed: Dec 30, 2025
1 condition
2 sponsors
1 location
NCT05934149
Lupus Landmark Study: A Prospective Registry and Biorepository
N/A
Recruiting
3,500 participants
Started: Jun 28, 2023 · Completed: Dec 31, 2035
3 conditions
1 sponsor
21 locations
NCT05671510
ONC-392 Versus Docetaxel in Metastatic NSCLC That Progressed on PD-1/PD-L1 Inhibitors
PHASE3
Recruiting
600 participants
Started: Jun 28, 2023 · Completed: Jun 30, 2027
1 condition
2 sponsors
160 locations
NCT06699446
"The Seamless Patient:From Preoperative Preparation to Postoperative Rehabilitation"
NA
Recruiting
300 participants
Started: Jun 28, 2023 · Completed: Dec 31, 2026
1 condition
1 sponsor
1 location
NCT05878769
A Study to Evaluate the Long-Term Safety of Astegolimab in Participants With Chronic Obstructive Pulmonary Disease (COPD)
PHASE3
Recruiting
2,000 participants
Started: Jun 28, 2023 · Completed: Jun 30, 2027
1 condition
1 sponsor
462 locations
NCT06345820
Comparison of Two Non-diffractive Enhanced Monofocal Intraocular Lenses
NA
Recruiting
35 participants
Started: Jun 28, 2023 · Completed: Jun 30, 2025
1 condition
1 sponsor
1 location
NCT05999448
Promoting the Well Being of Caregivers Via Telehealth
NA
Recruiting
800 participants
Started: Jun 28, 2023 · Completed: Dec 29, 2025
2 conditions
7 sponsors
1 location
NCT05396248
Improve New Learning and Memory in Individuals With Mild Cognitive Impairment
NA
Recruiting
120 participants
Started: Jun 28, 2023 · Completed: Mar 31, 2027
1 condition
3 sponsors
2 locations
NCT05672550
Dose-adjustment of Enoxaparin by a Bayesian Pharmacological Approach in Pediatric Kidney Transplant Recipients (OPTI-TREX)
PHASE4
Recruiting
50 participants
Started: Jun 28, 2023 · Completed: Oct 31, 2026
1 condition
1 sponsor
18 locations
NCT05661643
The Efficacy and Safety of Temozolomide in SDH-deficient GIST
PHASE2
Recruiting
29 participants
Started: Jun 28, 2023 · Completed: Dec 31, 2027
1 condition
1 sponsor
1 location
NCT05701241
Continuing Somatostatin Analogues Upon Progression in Neuroendocrine Tumour pAtients
PHASE4
Recruiting
270 participants
Started: Jun 28, 2023 · Completed: Apr 30, 2034
1 condition
4 sponsors
19 locations
NCT05783687
Real World Evidence Study in Subjects With Wilson's Disease
N/A
Active, not recruiting
50 participants
Started: Jun 28, 2023 · Completed: Dec 31, 2025
1 condition
1 sponsor
9 locations
NCT06516445
SCRT Followed by Camrelizumab Combined With Fluzoparib and Chemotherapy as Neoadjuvant Therapy for LARC
PHASE2
Recruiting
33 participants
Started: Jun 28, 2023 · Completed: Jun 28, 2026
1 condition
1 sponsor
1 location
NCT05725096
Role of Coronary CTA on Lipid Management and Risk Factors Control in an Asymptomatic Chinese Population
NA
Recruiting
3,400 participants
Started: Jun 28, 2023 · Completed: Jun 30, 2027
4 conditions
1 sponsor
1 location
NCT06016946
Friedreich Ataxia Global Clinical Consortium UNIFIED Natural History Study
N/A
Recruiting
3,000 participants
Started: Jun 28, 2023 · Completed: Jan 28, 2048
1 condition
1 sponsor
34 locations
NCT06018636
Impact of Diet and Nutrition on Growth and Development in Young Children
N/A
Recruiting
832 participants
Started: Jun 28, 2023 · Completed: Sep 30, 2028
7 conditions
4 sponsors
1 location
NCT06028555
International Active Surveillance Study: Native Estrogen Estetrol (E4) Safety Study
N/A
Recruiting
101,000 participants
Started: Jun 28, 2023 · Completed: Oct 31, 2028
2 conditions
3 sponsors
1 location
NCT05945433
Anovo™ Surgical System - Registry Study
N/A
Recruiting
300 participants
Started: Jun 28, 2023 · Completed: Jun 30, 2026
1 condition
1 sponsor
1 location
NCT05806099
A Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Efficacy Study of MBS303 in B-Cell NHL
PHASE1/PHASE2
Recruiting
132 participants
Started: Jun 28, 2023 · Completed: Nov 30, 2026
1 condition
1 sponsor
1 location
NCT05753137
Acupuncture as Adjuvant Therapy for Glaucoma - Protocol for a Randomized Controlled Trial
NA
Recruiting
50 participants
Started: Jun 28, 2023 · Completed: Jun 27, 2025
3 conditions
1 sponsor
1 location
NCT05768776
Outpatient Holmium LASER Enucleation of the Prostate: Benefit of MOSES(TM) 2.0 Technology
N/A
Active, not recruiting
200 participants
Started: Jun 28, 2023 · Completed: Jul 31, 2025
2 conditions
1 sponsor
1 location
NCT05954780
Selinexor (Nexpovio®) (SVd) in Patients With Relapsed or Refractory Multiple Myeloma
N/A
Recruiting
100 participants
Started: Jun 28, 2023 · Completed: Oct 30, 2026
1 condition
3 sponsors
2 locations
NCT05853965
Combination Treatment of Belantamab Mafodotin and Venetoclax in Treatment of Relapsed and Refractory T(11;14) Multiple Myeloma
PHASE1/PHASE2
Recruiting
45 participants
Started: Jun 28, 2023 · Completed: Dec 31, 2026
2 conditions
1 sponsor
5 locations
NCT06523647
Clinical Efficacy of Ustekinumab in Crohn's Disease
N/A
Recruiting
150 participants
Started: Jun 27, 2023 · Completed: Dec 31, 2025
1 condition
1 sponsor
4 locations
NCT06178185
A Novel Study Evaluating Patients Awaiting Total Hip Arthroplasty (PRIORITEES)
N/A
Recruiting
240 participants
Started: Jun 27, 2023 · Completed: Jun 27, 2024
1 condition
1 sponsor
1 location
NCT06018220
Percutaneous Dilatational Tracheostomy vs. Surgical Tracheostomy in Neurocritically Ill Patients - a Retrospective Study
N/A
Recruiting
383 participants
Started: Jun 27, 2023 · Completed: Jun 1, 2024
1 condition
1 sponsor
1 location
NCT05817318
Renal Denervation in Patients With Recurrent Atrial Fibrillation After Successful Pulmonary Vein Isolation
NA
Recruiting
40 participants
Started: Jun 27, 2023 · Completed: Dec 31, 2026
1 condition
2 sponsors
2 locations
NCT05885607
Early Metabolic Adaptations to SGLT2 Inhibition in Heart Failure
N/A
Enrolling by invitation
40 participants
Started: Jun 27, 2023 · Completed: Mar 31, 2026
3 conditions
2 sponsors
1 location
NCT06469632
Radiofrequency and Myofascial Pain Syndrome in Postpartum Pelvic Pain
NA
Recruiting
74 participants
Started: Jun 27, 2023 · Completed: Nov 30, 2025
1 condition
1 sponsor
1 location
NCT05838768
Study of HRO761 Alone or in Combination in Cancer Patients With Specific DNA Alterations Called Microsatellite Instability or Mismatch Repair Deficiency.
PHASE1
Recruiting
327 participants
Started: Jun 27, 2023 · Completed: May 30, 2029
1 condition
1 sponsor
30 locations
NCT05879978
A Study to Test How Well Different Doses of Obrixtamig (BI 764532) in Combination With Ezabenlimab Are Tolerated by People With Small Cell Lung Cancer and Other Neuroendocrine Tumours That Are Positive for DLL3
PHASE1/PHASE2
Active, not recruiting
45 participants
Started: Jun 27, 2023 · Completed: Dec 26, 2025
2 conditions
1 sponsor
8 locations
NCT05848050
Evaluation of the Humoral and Tumoral Molecular Alteration Profile of Brain Metastases
NA
Recruiting
30 participants
Started: Jun 27, 2023 · Completed: Apr 30, 2025
1 condition
2 sponsors
1 location
NCT06182098
Intravenous Fluids in Pediatric Migraine
NA
Recruiting
134 participants
Started: Jun 27, 2023 · Completed: Jun 30, 2025
2 conditions
1 sponsor
1 location
NCT05935904
Progression of Metabolic Syndrome Components During Pregnancy
N/A
Recruiting
526 participants
Started: Jun 27, 2023 · Completed: Dec 30, 2024
5 conditions
3 sponsors
1 location
NCT06052436
Cell Therapy With Treg Cells Obtained From Thymic Tissue (thyTreg) to Control the Immune Hyperactivation Associated With COVID-19 and/or Acute Respiratory Distress Syndrome (THYTECH2)
PHASE1/PHASE2
Recruiting
24 participants
Started: Jun 27, 2023 · Completed: Dec 31, 2027
1 condition
2 sponsors
1 location
NCT05732701
Algorithm-based Tailoring of Dual Antiplatelet Therapy to Improve Outcomes Following Percutaneous Coronary Interventions
NA
Recruiting
2,788 participants
Started: Jun 27, 2023 · Completed: Dec 31, 2028
3 conditions
1 sponsor
3 locations
NCT05389423
Pomalidomide and Dose-Adjusted EPOCH +/- Rituximab for HIV-Associated Lymphomas
PHASE1
Recruiting
25 participants
Started: Jun 27, 2023 · Completed: Jun 1, 2032
5 conditions
1 sponsor
1 location
NCT05227612
Psilocybin-assisted CBT for Depression
EARLY_PHASE1
Recruiting
62 participants
Started: Jun 27, 2023 · Completed: Dec 31, 2027
1 condition
2 sponsors
1 location
NCT05708352
A Phase 2 Study of the Ketogenic Diet vs Standard Anti-cancer Diet Guidance for Patients With Glioblastoma in Combination With Standard-of-care Treatment
PHASE2
Recruiting
170 participants
Started: Jun 27, 2023 · Completed: Sep 30, 2029
1 condition
2 sponsors
5 locations
NCT05933694
Spirometry Interpretation Performance of Primary Care Clinicians With/Without AI Software
NA
Recruiting
228 participants
Started: Jun 27, 2023 · Completed: Sep 30, 2024
1 condition
2 sponsors
1 location
NCT05799521
A Nasal Treatment for COVID-19
PHASE2
Recruiting
40 participants
Started: Jun 27, 2023 · Completed: Mar 30, 2026
1 condition
1 sponsor
1 location
NCT05919940
Improved Muscle Metabolism by Combination of Muscle Activation and Protein Substitution ( IMEMPRO )
NA
Recruiting
40 participants
Started: Jun 27, 2023 · Completed: Jan 31, 2026
6 conditions
6 sponsors
4 locations
Previous
1
More pages
1438
1439
1440
1441
1442
1443
1444
More pages
2369
Next